· 4/4/2014
Linda Messick v. Novartis Pharmaceuticals Corp.
Citations
- 747 F.3d 1193
- 94 Fed. R. Serv. 153
- 2014 WL 1328182
- 2014 U.S. App. LEXIS 6257
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- holding that the district court abused its discretion when it excluded expert testimony as unreliable because the expert could not determine which of multiple risk factors caused plaintiffs disease
- acknowledging that, even if a medical expert’s report prepared without examination or interview of the subject is in some instances admissible, the factfinder must still determine its weight
- reversing grant of summary judgment where expert’s testimony, which would have created a genuine issue of material fact, was excluded because it was erroneously deemed unreliable and irrelevant
- finding expert’s testimony relevant and reliable, but fact issues precluded summary 17 judgment on products liability claims
- reversing grant of summary judgment where expert’s testimony, which would have created a genuine issue PYRAMID TECH. V. ALLIED PUBLIC ADJUSTERS 15 of material fact, was excluded because it was erroneously deemed unreliable and irrelevant
- reversing grant of summary judgment where expert’s testimony, which would have created a genuine issue of material fact, was excluded because it was erroneously deemed unreliable and irrelevant
Source: CourtListener parenthetical corpus (CC0).
Judges: Fisher, Gould, Christen
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.